AngioDynamics Inc (ANGO)
Healthcare
Medical Instruments & Supplies
14.80 $
+0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns AngioDynamics Inc (ANGO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.9% of the shares are freely tradable; institutional investors hold 94.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
94.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
12.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
76.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
41Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.92 | 3,685,904 | -4.5 | 03/31/2026 |
| Point72 Asset Management, L.P. | 7.70 | 3,181,829 | +12.6 | 03/31/2026 |
| Systematic Financial Management LP | 5.94 | 2,453,701 | -2.0 | 03/31/2026 |
| Broadfin Holdings LLC | 5.01 | 2,069,333 | +0.0 | 03/31/2026 |
| Armistice Capital, LLC | 4.52 | 1,869,000 | +9.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.18 | 1,726,820 | +0.0 | 03/31/2026 |
| Royce & Associates, LP | 3.70 | 1,528,951 | +20.6 | 03/31/2026 |
| Weber Capital Management LLC | 3.32 | 1,373,149 | -1.9 | 03/31/2026 |
| State Street Corp | 3.23 | 1,333,858 | +4.8 | 03/31/2026 |
| Bastion Asset Management Inc. | 3.18 | 1,313,002 | +17.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 23,370 | 14.72 | 344,006 |
| 22. Jul 2026 | Piccinini Laura | SVP International | Other | 4,506 | 13.82 | 62,273 |
| 22. Jul 2026 | Piccinini Laura | SVP International | Other | 8,047 | 0.00 | – |
| 22. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 1,671 | 13.82 | 23,093 |
| 22. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 5,694 | 0.00 | – |
| 22. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 8,319 | 13.82 | 114,969 |
| 22. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 16,296 | 0.00 | – |
| 22. Jul 2026 | Clemmer James C | President and CEO | Other | 26,728 | 13.82 | 369,381 |
| 22. Jul 2026 | Clemmer James C | President and CEO | Other | 52,358 | 0.00 | – |
| 22. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 2,330 | 13.82 | 32,201 |
| 22. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 6,466 | 0.00 | – |
| 20. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 717 | 13.71 | 9,830 |
| 20. Jul 2026 | Piccinini Laura | SVP International | Other | 616 | 13.71 | 8,445 |
| 20. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 251 | 13.71 | 3,441 |
| 20. Jul 2026 | Clemmer James C | President and CEO | Other | 4,223 | 13.71 | 57,897 |
| 20. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 359 | 13.71 | 4,922 |
| 19. Jul 2026 | Clemmer James C | President and CEO | Other | 487 | 13.51 | 6,579 |
| 19. Jul 2026 | Clemmer James C | President and CEO | Other | 11,764 | 13.51 | 158,932 |
| 17. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 3,510 | 13.51 | 47,420 |
| 17. Jul 2026 | Piccinini Laura | SVP International | Other | 3,074 | 13.51 | 41,530 |
| 17. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 1,373 | 13.51 | 18,549 |
| 17. Jul 2026 | Clemmer James C | President and CEO | Other | 10,649 | 13.51 | 143,868 |
| 17. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 1,112 | 13.51 | 15,023 |
| 16. Jul 2026 | Weiss Lawrence T | SVP, Chief Legal Officer | Other | 2,267 | 14.14 | 32,055 |
| 16. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 7,840 | 14.14 | 110,858 |
| 16. Jul 2026 | Piccinini Laura | SVP International | Other | 4,538 | 14.14 | 64,167 |
| 16. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 2,153 | 14.14 | 30,443 |
| 16. Jul 2026 | Clemmer James C | President and CEO | Other | 18,588 | 14.14 | 262,834 |
| 16. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 2,367 | 14.14 | 33,469 |
| 15. Jul 2026 | Reed Jan Stern | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Licitra Karen A | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Johnson Wesley | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Donnelly Howard W | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Burgess Lorinda | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Auen Eileen O'Shea | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Tarnoff Michael E | Director | Other | 11,887 | 0.00 | – |
| 15. Jul 2026 | Trowbridge Stephen A | EVP and CFO | Other | 53,257 | 0.00 | – |
| 15. Jul 2026 | Piccinini Laura | SVP International | Other | 19,860 | 0.00 | – |
| 15. Jul 2026 | Nighan Warren JR | SVP Quality and Regulatory | Other | 17,966 | 0.00 | – |
| 15. Jul 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | Other | 16,081 | 0.00 | – |
| 15. Jul 2026 | Weiss Lawrence T | SVP, Chief Legal Officer | Other | 21,288 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.